<DOC>
	<DOCNO>NCT00225121</DOCNO>
	<brief_summary>The primary purpose study study side effect PF-00299804 determine high dose safely administer patient advanced cancer .</brief_summary>
	<brief_title>Study To Evaluate The Safety , Pharmacokinetics , And Pharmacodynamics Of PF-00299804 In Patients With Advanced Solid Tumors</brief_title>
	<detailed_description />
	<criteria>Malignant solid tumor currently approve treatment Adequate bone marrow , liver , cardiac , kidney function Cardiac disease Anticancer therapy within 46 week ( depend therapy ) Pregnant breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
</DOC>